Cargando…
Assessment of [(125)I]WYE-230949 as a Novel Histamine H(3) Receptor Radiopharmaceutical
Histamine H(3) receptor therapeutics have been proposed for several diseases such as schizophrenia, attention deficit hyperactivity disorder, Alzheimer's disease and obesity. We set out to evaluate the novel compound, [(125)I]WYE-230949, as a potential radionuclide imaging agent for the histami...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4277420/ https://www.ncbi.nlm.nih.gov/pubmed/25542008 http://dx.doi.org/10.1371/journal.pone.0115876 |